Herbal combinations against COVID-19: A network pharmacology, molecular docking and dynamics study

IF 4.2 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE
Jian-bo Song , Li-qin Zhao , Hong-ping Wen , Yuan-ping Li
{"title":"Herbal combinations against COVID-19: A network pharmacology, molecular docking and dynamics study","authors":"Jian-bo Song ,&nbsp;Li-qin Zhao ,&nbsp;Hong-ping Wen ,&nbsp;Yuan-ping Li","doi":"10.1016/j.joim.2023.09.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>The aim of this study is to identify molecules from traditional Chinese medicine<span> (TCM) with potential activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants.</span></p></div><div><h3>Methods</h3><p><span><span>We applied the Apriori algorithm to identify important combinations of herbs in the TCM prescriptions for the treatment of </span>coronavirus disease 2019 (COVID-19). Then, we explored the active components and core targets using network pharmacology. In addition, the </span>molecular docking approach was performed to investigate the interaction of these components with the main structural and non-structural proteins, as well as the mutants. Furthermore, their stability in the binding pockets was further evaluated with the molecular dynamics approach.</p></div><div><h3>Results</h3><p>A combination of <em>Amygdalus Communis</em> Vas., <span><em>Ephedra</em><em> Herba</em></span> and <span><em>Scutellaria baicalensis</em></span><span><span><span> Georgi was selected as the important herbal combination, and 11 main components and 20 core targets against COVID-19 were obtained. These components, including luteolin, </span>naringenin, </span>stigmasterol<span><span>, baicalein, and so on, were the potentially active compounds against COVID-19. The </span>binding affinity of these compounds with the potential targets was as high as the positive controls. Among them, baicalein could interfere with multiple targets simultaneously, and it also interfered with the interaction between spike protein and angiotensin-converting enzyme 2 receptor. Additionally, almost all the systems reached stability during dynamics simulation.</span></span></p></div><div><h3>Conclusion</h3><p>The combination of <em>A</em>. c<em>ommunis</em>, <em>Ephedra Herba</em> and <em>S</em>. <em>baicalensis</em> was the most important herbal combination for the treatment of COVID-19. Baicalein may be a potential candidate against SARS-CoV-2 and its variants.</p><p>Please cite this article as: Song JB, Zhao LQ, Wen HP, Li YP. Herbal combinations against COVID-19: A network pharmacology, molecular docking and dynamics study. <em>J Integr Med</em>. 2023;21(6):593–604.</p></div>","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"21 6","pages":"Pages 593-604"},"PeriodicalIF":4.2000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Integrative Medicine-Jim","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2095496423000778","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

The aim of this study is to identify molecules from traditional Chinese medicine (TCM) with potential activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants.

Methods

We applied the Apriori algorithm to identify important combinations of herbs in the TCM prescriptions for the treatment of coronavirus disease 2019 (COVID-19). Then, we explored the active components and core targets using network pharmacology. In addition, the molecular docking approach was performed to investigate the interaction of these components with the main structural and non-structural proteins, as well as the mutants. Furthermore, their stability in the binding pockets was further evaluated with the molecular dynamics approach.

Results

A combination of Amygdalus Communis Vas., Ephedra Herba and Scutellaria baicalensis Georgi was selected as the important herbal combination, and 11 main components and 20 core targets against COVID-19 were obtained. These components, including luteolin, naringenin, stigmasterol, baicalein, and so on, were the potentially active compounds against COVID-19. The binding affinity of these compounds with the potential targets was as high as the positive controls. Among them, baicalein could interfere with multiple targets simultaneously, and it also interfered with the interaction between spike protein and angiotensin-converting enzyme 2 receptor. Additionally, almost all the systems reached stability during dynamics simulation.

Conclusion

The combination of A. communis, Ephedra Herba and S. baicalensis was the most important herbal combination for the treatment of COVID-19. Baicalein may be a potential candidate against SARS-CoV-2 and its variants.

Please cite this article as: Song JB, Zhao LQ, Wen HP, Li YP. Herbal combinations against COVID-19: A network pharmacology, molecular docking and dynamics study. J Integr Med. 2023;21(6):593–604.

抗新冠肺炎的草药组合:网络药理学、分子对接和动力学研究。
目的:本研究的目的是从中药中鉴定对严重急性呼吸综合征冠状病毒2型及其变异株具有潜在活性的分子。方法:应用Apriori算法识别2019冠状病毒病(新冠肺炎)中医处方中的重要草药组合。然后,我们利用网络药理学对其活性成分和核心靶点进行了探索。此外,还采用分子对接方法研究了这些成分与主要结构蛋白和非结构蛋白以及突变体的相互作用。此外,用分子动力学方法进一步评估了它们在结合口袋中的稳定性。结果:杏仁核共有血管。,选用麻黄和黄芩为重要的中草药组合,获得11个主要成分和20个核心靶点,对抗新冠肺炎。这些成分包括木犀草素、柚皮素、豆甾醇、黄芩素等,是抗新冠肺炎的潜在活性化合物。这些化合物与潜在靶标的结合亲和力与阳性对照一样高。其中,黄芩素可以同时干扰多个靶点,还可以干扰刺突蛋白与血管紧张素转换酶2受体之间的相互作用。此外,在动力学仿真过程中,几乎所有系统都达到了稳定性。结论:共产草、麻黄、黄芩联合用药是治疗新冠肺炎最重要的中药组合。黄芩苷可能是对抗严重急性呼吸系统综合征冠状病毒2型及其变异株的潜在候选药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Integrative Medicine-Jim
Journal of Integrative Medicine-Jim Medicine-Complementary and Alternative Medicine
CiteScore
9.20
自引率
4.20%
发文量
3319
期刊介绍: The predecessor of JIM is the Journal of Chinese Integrative Medicine (Zhong Xi Yi Jie He Xue Bao). With this new, English-language publication, we are committed to make JIM an international platform for publishing high-quality papers on complementary and alternative medicine (CAM) and an open forum in which the different professions and international scholarly communities can exchange views, share research and their clinical experience, discuss CAM education, and confer about issues and problems in our various disciplines and in CAM as a whole in order to promote integrative medicine. JIM is indexed/abstracted in: MEDLINE/PubMed, ScienceDirect, Emerging Sources Citation Index (ESCI), Scopus, Embase, Chemical Abstracts (CA), CAB Abstracts, EBSCO, WPRIM, JST China, Chinese Science Citation Database (CSCD), and China National Knowledge Infrastructure (CNKI). JIM Editorial Office uses ThomsonReuters ScholarOne Manuscripts as submitting and review system (submission link: http://mc03.manuscriptcentral.com/jcim-en). JIM is published bimonthly. Manuscripts submitted to JIM should be written in English. Article types include but are not limited to randomized controlled and pragmatic trials, translational and patient-centered effectiveness outcome studies, case series and reports, clinical trial protocols, preclinical and basic science studies, systematic reviews and meta-analyses, papers on methodology and CAM history or education, conference proceedings, editorials, commentaries, short communications, book reviews, and letters to the editor. Our purpose is to publish a prestigious international journal for studies in integrative medicine. To achieve this aim, we seek to publish high-quality papers on any aspects of integrative medicine, such as acupuncture and traditional Chinese medicine, Ayurveda medicine, herbal medicine, homeopathy, nutrition, chiropractic, mind-body medicine, taichi, qigong, meditation, and any other modalities of CAM; our commitment to international scope ensures that research and progress from all regions of the world are widely covered. These ensure that articles published in JIM have the maximum exposure to the international scholarly community. JIM can help its authors let their papers reach the widest possible range of readers, and let all those who share an interest in their research field be concerned with their study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信